Antioxidant micronutrients and the risk of renal cell carcinoma in the Women's Health Initiative cohort

Cancer

Volumn 121, Issue 4, 2015, Pages 580-588

  Ho, Won Jin ^a   Simon, Michael S ^b   Yildiz, Vedat O ^c   Shikany, James M ^d   Kato, Ikuko ^b   Beebe Dimmer, Jennifer L ^b   Cetnar, Jeremy P ^e   Bock, Cathryn H ^b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d and Clinical Center   (United States)

^e UNIVERSITY OF WISCONSIN   (United States)

Author keywords

Antioxidants; Carotenoids; Lycopene; Postmenopausal women; Renal cell carcinoma

Indexed keywords

ALPHA CAROTENE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; BETA CRYPTOXANTHIN; LYCOPENE; TRACE ELEMENT; XANTHOPHYLL; ZEAXANTHIN; CAROTENOID; CRYPTOXANTHIN;

ADULT; AGED; ARTICLE; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATIONAL STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FOOD FREQUENCY QUESTIONNAIRE; HUMAN; INTERVIEW; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MIDDLE AGED; MULTICENTER STUDY (TOPIC); POSTMENOPAUSE; REPRODUCTIVE HISTORY; RISK ASSESSMENT; RISK REDUCTION; CARCINOMA, RENAL CELL; CLINICAL TRIAL (TOPIC); KIDNEY NEOPLASMS; PROPORTIONAL HAZARDS MODEL; RISK; TREATMENT OUTCOME; WOMEN'S HEALTH;

AGED; ANTIOXIDANTS; ASCORBIC ACID; CARCINOMA, RENAL CELL; CAROTENOIDS; CLINICAL TRIALS AS TOPIC; CRYPTOXANTHINS; DIETARY SUPPLEMENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY NEOPLASMS; LUTEIN; MICRONUTRIENTS; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; ODDS RATIO; POSTMENOPAUSE; PROPORTIONAL HAZARDS MODELS; TREATMENT OUTCOME; VITAMIN E; WOMEN'S HEALTH; ZEAXANTHINS;

EID: 84922569219     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29091     Document Type: Article

References (48)

1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9-29.
2. Chow WH, Dong LM, Devesa SS. Epidemiology and risk factors for kidney cancer. Nat Rev Urol. 2010;7:245-257.
3. Heath CW Jr, Lally CA, Calle EE, McLaughlin JK, Thun MJ. Hypertension, diuretics, and antihypertensive medications as possible risk factors for renal cell cancer. Am J Epidemiol. 1997;145:607-613.
4. Hunt JD, van der Hel OL, McMillan GP, Boffetta P, Brennan P. Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies. Int J Cancer. 2005;114:101-108.
5. McLaughlin JK, Silverman DT, Hsing AW, et al. Cigarette smoking and cancers of the renal pelvis and ureter. Cancer Res. 1992;52:254-257.
6. Moore SC, Chow WH, Schatzkin A, et al. Physical activity during adulthood and adolescence in relation to renal cell cancer. Am J Epidemiol. 2008;168:149-157.
7. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Bodymass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371:569-578.
8. Purdue MP, Moore LE, Merino MJ, et al. An investigation of risk factors for renal cell carcinoma by histologic subtype in 2 case-control studies. Int J Cancer. 2013;132:2640-2647.
9. Sharifi N, Farrar WL. Perturbations in hypoxia detection: a shared link between hereditary and sporadic tumor formation? Med Hypotheses. 2006;66:732-735.
10. Klinghoffer Z, Yang B, Kapoor A, Pinthus JH. Obesity and renal cell carcinoma: epidemiology, underlying mechanisms and management considerations. Expert Rev Anticancer Ther. 2009;9:975-987.
11. Sharoni Y, Linnewiel-Hermoni K, Khanin M, et al. Carotenoids and apocarotenoids in cellular signaling related to cancer: a review. Mol Nutr Food Res. 2012;56:259-269.
12. Gao P, Zhang H, Dinavahi R, et al. HIF-dependent anti-tumorigenic effect of antioxidants in vivo. Cancer Cell. 2007;12:230-238.
13. Bertoia M, Albanes D, Mayne ST, Mannisto S, Virtamo J, Wright ME. No association between fruit, vegetables, antioxidant nutrients and risk of renal cell carcinoma. Int J Cancer. 2010;126:1504-1512.
14. Prineas RJ, Folsom AR, Zhang ZM, Sellers TA, Potter J. Nutrition and other risk factors for renal cell carcinoma in postmenopausal women. Epidemiology. 1997;8:31-36.
15. Virtamo J, Edwards BK, Virtanen M, et al. Effects of supplemental alpha-tocopherol and beta-carotene on urinary tract cancer: incidence and mortality in a controlled trial (Finland). Cancer Causes Control. 2000;11:933-939.
16. Bosetti C, Scotti L, Maso LD, et al. Micronutrients and the risk of renal cell cancer: a case-control study from Italy. Int J Cancer. 2007;120:892-896.
17. Hu J, Mao Y, White K. Diet and vitamin or mineral supplements and risk of renal cell carcinoma in Canada. Cancer Causes Control. 2003;14:705-714.
18. Lindblad P, Wolk A, Bergstrom R, Adami HO. Diet and risk of renal cell cancer: a population-based case-control study. Cancer Epidemiol Biomarkers Prev. 1997;6:215-223.
19. Yuan JM, Gago-Dominguez M, Castelao JE, Hankin JH, Ross RK, Yu MC. Cruciferous vegetables in relation to renal cell carcinoma. Int J Cancer. 1998;77:211-216.
20. Lee JE, Giovannucci E, Smith-Warner SA, Spiegelman D, Willett WC, Curhan GC. Intakes of fruits, vegetables, vitamins A, C, and E, and carotenoids and risk of renal cell cancer. Cancer Epidemiol Biomarkers Prev. 2006;15:2445-2452.
21. Karami S, Daugherty SE, Schonfeld SJ, et al. Reproductive factors and kidney cancer risk in 2 US cohort studies, 1993-2010. Am J Epidemiol. 2013;177:1368-1377.
22. Nicodemus KK, Sweeney C, Folsom AR. Evaluation of dietary, medical and lifestyle risk factors for incident kidney cancer in postmenopausal women. Int J Cancer. 2004;108:115-121.
23. Patterson RE, Kristal AR, Tinker LF, Carter RA, Bolton MP, Agurs-Collins T. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Ann Epidemiol. 1999;9:178-187.
24. Schakel SF, Sievert YA, Buzzard IM. Sources of data for developing and maintaining a nutrient database. J Am Diet Assoc. 1988;88:1268-1271.
25. Shikany JM, Patterson RE, Agurs-Collins T, Anderson G. Antioxidant supplement use in Women's Health Initiative participants. Prev Med. 2003;36:379-387.
26. Cui Y, Shikany JM, Liu S, Shagufta Y, Rohan TE. Selected antioxidants and risk of hormone receptor-defined invasive breast cancers among postmenopausal women in the Women's Health Initiative Observational Study. Am J Clin Nutr. 2008;87:1009-1018.
27. Curb JD, McTiernan A, Heckbert SR, et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Ann Epidemiol. 2003;13:S122-S128.
28. Bramley PM. Is lycopene beneficial to human health? Phytochemistry. 2000;54:233-236.
29. Wang XD. Lycopene metabolism and its biological significance. Am J Clin Nutr. 2012;96:1214S-1222S.
30. Xu X, Wang Y, Constantinou AI, Stacewicz-Sapuntzakis M, Bowen PE, van Breemen RB. Solubilization and stabilization of carotenoids using micelles: delivery of lycopene to cells in culture. Lipids. 1999;34:1031-1036.
31. Di Mascio P, Kaiser S, Sies H. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys. 1989;274:532-538.
32. Hu J, La Vecchia C, Negri E, DesMeules M, Mery L. Dietary vitamin C, E, and carotenoid intake and risk of renal cell carcinoma. Cancer Causes Control. 2009;20:1451-1458.
33. Lee JE, Mannisto S, Spiegelman D, et al. Intakes of fruit, vegetables, and carotenoids and renal cell cancer risk: a pooled analysis of 13 prospective studies. Cancer Epidemiol Biomarkers Prev. 2009;18:1730-1739.
34. Brock KE, Ke L, Gridley G, et al. Fruit, vegetables, fibre and micronutrients and risk of US renal cell carcinoma. Br J Nutr. 2012;108:1077-1085.
35. Eliassen AH, Hendrickson SJ, Brinton LA, et al. Circulating carotenoids and risk of breast cancer: pooled analysis of 8 prospective studies. J Natl Cancer Inst. 2012;104:1905-1916.
36. Etminan M, Takkouche B, Caamano-Isorna F. The role of tomato products and lycopene in the prevention of prostate cancer: a meta-analysis of observational studies. Cancer Epidemiol Biomarkers Prev. 2004;13:340-345.
37. Giovannucci E. Tomato products, lycopene, and prostate cancer: a review of the epidemiological literature. J Nutr. 2005;135:2030S-2031S.
38. Levy J, Bosin E, Feldman B, et al. Lycopene is a more potent inhibitor of human cancer cell proliferation than either alpha-carotene or beta-carotene. Nutr Cancer. 1995;24:257-266.
39. Sharoni Y, Linnewiel-Hermoni K, Zango G, et al. The role of lycopene and its derivatives in the regulation of transcription systems: implications for cancer prevention. Am J Clin Nutr. 2012;96:1173S-1178S.
40. Aydin S, Palabiyik SS, Erkekoglu P, Sahin G, Basaran N, Giray BK. The carotenoid lycopene protects rats against DNA damage induced by Ochratoxin A. Toxicon. 2013;73:96-103.
41. Dogukan A, Tuzcu M, Agca CA, et al. A tomato lycopene complex protects the kidney from cisplatin-induced injury via affecting oxidative stress as well as Bax, Bcl-2, and HSPs expression. Nutr Cancer. 2011;63:427-434.
42. Huff JE. Carcinogenicity of ochratoxin A in experimental animals. IARC Sci Publ. 1991;114:229-244.
43. Wilson CL, Ness KK, Neglia JP, et al. Renal carcinoma after childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2013;105:504-508.
44. Parker AS, Cheville JC, Blute ML, Igel T, Lohse CM, Cerhan JR. Pathologic T1 clear cell renal cell carcinoma: insulin-like growth factor-I receptor expression and disease-specific survival. Cancer. 2004;100:2577-2582.
45. Pantuck AJ, An J, Liu H, Rettig MB. NF-kappaB-dependent plasticity of the epithelial to mesenchymal transition induced by Von Hippel-Lindau inactivation in renal cell carcinomas. Cancer Res. 2010;70:752-761.
46. Peri S, Devarajan K, Yang DH, Knudson AG, Balachandran S. Meta-analysis identifies NF-kappaB as a therapeutic target in renal cancer [serial online]. PLoS One. 2013;8:e76746.
47. Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Data. Hyattsville, MD: Department of Health and Human Services, Centers for Disease Control and Prevention; 2014.
48. Casagrande SS, Wang Y, Anderson C, Gary TL. Have Americans increased their fruit and vegetable intake? The trends between 1988 and 2002. Am J Prev Med. 2007;32:257-263.